Ameridose LLC, an affiliate of the drug-compounding pharmacy at the center of a deadly fugal meningitis outbreak in the United States, is cutting 650 positions as it grapples with an indefinite closure following regulatory scrutiny of its sterilization practices.
According to the Boston Globe, Ameridose employees have been notified of their pending termination from the company, effective Friday.
“While we continue to expect to resume operations, we have now determined that because of the continued inspection by state and federal authorities it may be necessary to resume operations at a reduced level,” read a letter, cited by the Globe, to affected workers from Ameridose’s director of human resources, Geri Weinstein…
Choosen excerpts by JMM from
via Local drug firms to cut 790 jobs as a result of deadly meningitis outbreak – Boston Business Journal.




Discussion
No comments yet.